Literature DB >> 31910153

The endocrine disruptor DEHP and the ECS: analysis of a possible crosstalk.

Jana Ernst1, Urszula Grabiec2, Kathrin Falk3, Faramarz Dehghani4, Kristina Schaedlich5.   

Abstract

Studies of the last decade associated the environmental contamination by di-(2-ethylhexyl)-phthalate (DEHP) with obesity and endocrine malfunction. DEHP was found to interact with several receptors - among them receptors of the endocannabinoid system (ECS) with high expression levels in adipose tissue. Furthermore, the correlation for BMI and body fat to the serum endocannabinoid level raises the question if the obesogenic and endocrine-disrupting DEHP-effects are mediated via the ECS. We therefore characterized the ECS in a human cell model of adipogenesis using the SGBS preadipocytes to subsequently investigate if DEHP-exposure affects the intrinsic ECS. The receptors of the ECS and the endocannabinoid-metabolizing enzymes were up-regulated during normal adipogenesis, accompanied by an increasing secretion of the adipokines adiponectin and leptin. DEHP affected the secretion of both adipokines but not the ECS, suggesting DEHP to alter the endocrine function of adipocytes without the involvement of the intrinsic ECS.

Entities:  

Year:  2020        PMID: 31910153     DOI: 10.1530/EC-19-0548

Source DB:  PubMed          Journal:  Endocr Connect        ISSN: 2049-3614            Impact factor:   3.335


  2 in total

1.  Analysis of Risk Factors of Coronary Heart Disease and Its Correlation with Inflammatory Factors in Patients with Type 2 Diabetes Mellitus.

Authors:  Zhigang Wang; Hui Zhao; Qian Zhou
Journal:  Biomed Res Int       Date:  2022-06-24       Impact factor: 3.246

Review 2.  A novel strategy for treating cancer: understanding the role of Ca2+ signaling from nociceptive TRP channels in regulating cancer progression.

Authors:  Wen-Li Hsu; Mami Noda; Tohru Yoshioka; Etsuro Ito
Journal:  Explor Target Antitumor Ther       Date:  2021-10-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.